Daniel E. Kremens, MD, JD

August 15, 2022

Despite the availability of medications to relieve OFF episodes in Parkinson disease, widespread adoption of on-demand therapies has been less-than-ideal, marking the need to shift the treatment paradigm in PD.

November 23, 2021

Expert neurologists provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.

November 23, 2021

Key opinion leaders explain the use of sublingual apomorphine and trimethobenzamide for Parkinson’s disease.

November 16, 2021

A panel of experts debate the disadvantages and side effects of apomorphine therapies for Parkinson’s disease.

November 16, 2021

A discussion on the use of apomorphine subcutaneous injections in managing Parkinson’s disease.

November 09, 2021

Neurologists debate the use of levodopa inhalation powder in managing Parkinson’s disease.

November 09, 2021

Physicians discuss when to add on-demand therapies to Parkinson’s disease management.

November 02, 2021

Key opinion leaders explain the important attributes to consider when choosing an on-demand therapy.

November 02, 2021

Experts debate the challenges of carbidopa/levodopa, and the relation between levodopa and the gut.

October 26, 2021

Panelists describe the motor and non-motor symptoms of Parkinson’s disease, linking symptoms to OFF episodes, and how to educate patients.